FDA Warning Letter — East Capital Exxon

Case 706701 — FEI 3015114338

The FDA took a Warning Letter action against East Capital Exxon on Apr 15, 2025 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
East Capital Exxon
Date
Apr 15, 2025
Fiscal Year
2025
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.